Company intelligence / Profile preview
Kracie
- Ownership
- Private
- Employees
- ~1790
- Development stage
- Commercial
Overview
Kracie is a leading Japanese company with commercialized products across pharmaceuticals, personal care/cosmetics, and food sectors. Its pharmaceutical business centers on Kampo medicines—traditional Japanese herbal remedies—offered both as prescription drugs for medical institutions and as over-the-counter products for consumers. The company holds the largest market share in Japan for OTC Kampo medicines sold face-to-face at pharmacies and drugstores. No recent clinical trial results are publicly highlighted; the portfolio consists of established commercial products.
- Therapeutic areas
- Metabolic DisordersOtherDermatologyNephrologyInfectious Diseases
- Modalities
- Small molecule (for OTC and ethical drugs)Herbal medicine (Kampo medicines)
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Kracie.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kracie.